Partner Headlines - BIIB

  1. Medivation Tops Q4 Views On Strong Xtandi Results

    IBD
  2. The Catalysts Biogen Idec Investors Should Watch

    Benzinga
  3. United Therapeutics Blood Pressure Drug Spurs Q4 Beat

    IBD
  4. Drugmaker Mylan Takes Part In Pharma Feeding Frenzy

    IBD
  5. Pharma M&A: Bristol-Myers, Valeant Make Deals

    IBD
  6. Evercore ISI Technical Analysis: The 'Single Best Idea'

    Benzinga
  7. February Pick Of Biotech Stocks

    GuruFocus
  8. Stanley Druckenmiller's Recent Trades

    GuruFocus
  9. 8 Strong Recommendations for 2015

    GuruFocus
  10. Stocks End Mixed: Molina Healthcare Rises Again

    IBD
  11. Stocks Open Mixed, Techs Climb; Rite Aid, Akamai, AmTrust Jump

    IBD
  12. Regeneron Q4 Sales, 2015 Outlook Upbeat On Eylea

    IBD
  13. No Deceleration Here: 14 Stocks With Accelerating Profits

    IBD
  14. Nuveen's Bob Doll Runs Several Top Funds

    IBD
  15. Top Performing Funds Favor Leisure, Medical, REITs

    IBD
  16. iShares NASDAQ Biotech ETF Pulls Back Off All-Time Highs

    Benzinga
  17. Super Bowl Stocks: Seattle's Best Vs. Boston Strong

    IBD
  18. Many Leading Stocks Stumble But Biogen, Harman Soar

    IBD
  19. Stocks Slide Into Closing Bell; Day's Winners: Amazon, Biogen

    IBD
  20. Indexes Mired In Red; Amazon, Biogen, Visa Buck Trend

    IBD
  21. Stocks Extend Losses; Biogen Idec Gains

    IBD
  22. Stocks Open Down In Weak Trade; Biogen, Visa Soar On Q4 Results

    IBD
  23. Stocks Hitting 52-Week Highs

    Benzinga
  24. Morning Market Gainers

    Benzinga
  25. Friday Morning Movers: Amazon Pops, Deckers Outdoor Plummets ...

    Benzinga
  26. Biotechs' Earnings Buoy Street Despite FX Headwinds

    IBD
  27. Biogen, Alexion Soar On EPS

    IBD
  28. Making Money With Charles Payne: 01/29/15

    FoxBusiness
  29. Biogen Idec Q4 Net Nearly Doubles; Beats Views

    Benzinga
  30. Alexion Beats Q4 Estimates, Appoints New CEO

    IBD
  31. Credit Suisse Previews Biogen, Says 'Consensus Tecfidera Downgrades ...

    Benzinga
  32. Earnings Scheduled For January 29, 2015

    Benzinga
  33. Biotech Stocks Down Despite Strong Amgen Quarter

    IBD
  34. Stocks Fade Badly; EA Hangs Tough

    IBD
  35. Earnings Scheduled For January 28, 2015

    Benzinga
  36. Must Watch Stocks for January 28, 2015

    Benzinga
  37. Big Cap Stocks Mylan, American Tower Near Buy Points

    IBD
  38. 5 Big Biotech Earnings Releases To Watch This Week

    Benzinga
  39. Apple, Facebook Lead This Week's IBD 50 Earnings

    IBD
  40. Apple, Facebook Lead Top IBD 50 Earnings This Week

    IBD
  41. IBD 50 Turns In Solid Week As Market Uptrend Resumes

    IBD
  42. The 5 Biggest Biotech Stocks

    Benzinga
  43. Jefferies 'Encouraged' By Biogen Idec's New Data

    Benzinga
  44. Nomura's Takeways From Biogen Idec's Analyst Meeting

    Benzinga
  45. Biogen Idec To Acquire Convergence Pharmaceuticals In Deal Worth ...

    Benzinga
  46. Meet 5 Top Medical Stocks Making Waves This Week

    IBD
  47. Stocks Turn Negative; Goodyear Triggers Sell Signal

    IBD
  48. A Look At 3 Biotech Stocks With Upside Potential

    Benzinga
  49. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  50. Stocks Reverse Lower On Good News/Bad News Job Data

    IBD
  51. Biogen drug results mixed

    IBD
  52. Nasdaq, S&P 500 Gap Up At Open, Hold Strong Gains

    IBD
  53. Biogen Nerve-Repair Drug Yields Mixed Results

    IBD
  54. Stock Market Surges; Nasdaq, S&P 500 Retake 50-Day Lines

    IBD
  55. Stocks Poised For Early Pop; Global Payments Gains

    IBD
  56. Stock Indexes Gun For Best Pop In 3 Weeks; Monster Breaks Out

    IBD
  57. Late-Session Rally Fades; Stocks End Firmly Lower

    IBD
  58. Oil's Drop Spooks Market Again, But REITs Outperform

    IBD
  59. Stocks Take It On The Chin Again; 10-Year Yield Plummets

    IBD
  60. J.P. Morgan Chimes In With Ratings On BioTech Stocks

    GuruFocus
  61. What Investors Are Looking For In NPS Pharmaceuticals Ahead Of ...

    Benzinga
  62. Benzinga's Top Initiations

    Benzinga
  63. Barclays Initiates Biogen Idec At Overweight

    Benzinga
  64. Hot Biotech Stocks: Isis, Kite Jump On Big Deals

    IBD
  65. Isis Pharma To Develop GI Drugs With J&J

    IBD
  66. An Investor's Guide: Market-Leading Industries In 2014

    IBD
  67. Stocks Reverse Lower; Apple Plunges Below Support

    IBD
  68. Stocks Surrender Early Gains, But Chip Stocks Outperform

    IBD
  69. 5 Biotech Stocks With Big News Due In January

    IBD
  70. Will 2015 Be Different For Big Cap Stocks?

    IBD
  71. Are There Any Winners Left In The Biotech Space?

    Benzinga
  72. How Gilead And Johnson & Johnson's Tumble Affected These Hedge ...

    Benzinga
  73. Fresh Milestones For Dow, S&P 500 But Biotechs Hit

    IBD
  74. Toys, Department Stores Rock, But Biotechs Tumble

    IBD
  75. Indexes Turn Mixed On Data; Celgene Dives

    IBD
  76. Express Scripts Picks AbbVie HCV Drugs Over Gilead

    IBD
  77. Broad Indexes Little Changed; Facebook Breaks Out

    IBD
  78. Stocks Struggle To Hold Gains; Alaska Air, Spirit Up

    IBD
  79. Morning Market Losers

    Benzinga
  80. Benzinga's Top #PreMarket Losers

    Benzinga
  81. Stocks Press Higher; Biotechs Gilead, Biogen Rise

    IBD
  82. Roche Drugs For Alzheimer's, Breast Cancer Disappoint

    IBD
  83. Juiced By Fed, Stocks Rocket Higher; Biogen Up 6%

    IBD
  84. Stocks Hold Near Session Highs; FedEx Bounces Back

    IBD
  85. Meet 5 Top Biotech Stocks Holding Up In Shaky Market

    IBD
  86. United Therapeutics: Will It Pass Peers In 2015?

    IBD
  87. Lilly Upgraded On 2 Potential Blockbuster Drugs

    IBD
  88. The Biotech Stock With The Most Upside In 2015, According To ...

    Benzinga
  89. Pfizer Spreading Its Wings Into A New Domain Of Life Sciences

    GuruFocus
  90. 3 Biotech ETFs Rally On Merger News

    Benzinga
  91. Hot Drugmakers Build More Labs, Grab Space In Boston

    IBD
  92. Will New Alzheimer's Drug Boost Biogen?

    IBD
  93. Stock Market Today: Stocks Worsen Near Midday; Airlines Rally

    IBD
  94. Biogen's Alzheimer's Drug Moves to Phase III

    GuruFocus
  95. Stock Market Today: Indexes Close Near Day's Highs

    IBD
  96. Great News For Biogen, But What's Next For The Stock?

    Benzinga
  97. Biogen Drug Test Advances

    IBD
  98. Stock Market Today: Indexes Trade Near Session Highs

    IBD
  99. Deutsche Bank Sees More Upside For Biogen

    Benzinga
  100. Biogen Alzheimer's Drug Succeeding In Early Tests

    IBD
Trading Center